JP2013540702A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013540702A5 JP2013540702A5 JP2013524419A JP2013524419A JP2013540702A5 JP 2013540702 A5 JP2013540702 A5 JP 2013540702A5 JP 2013524419 A JP2013524419 A JP 2013524419A JP 2013524419 A JP2013524419 A JP 2013524419A JP 2013540702 A5 JP2013540702 A5 JP 2013540702A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclic peptide
- linked cyclic
- aminooxy functionalized
- met
- met linked
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010069514 Cyclic Peptides Proteins 0.000 claims 1
- 102000001189 Cyclic Peptides Human genes 0.000 claims 1
- 125000002344 aminooxy group Chemical group [H]N([H])O[*] 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1013808.9 | 2010-08-18 | ||
| GBGB1013808.9A GB201013808D0 (en) | 2010-08-18 | 2010-08-18 | Peptide radiotracer compositions |
| PCT/EP2011/063890 WO2012022676A1 (en) | 2010-08-18 | 2011-08-11 | Peptide radiotracer compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013540702A JP2013540702A (ja) | 2013-11-07 |
| JP2013540702A5 true JP2013540702A5 (enExample) | 2014-09-18 |
| JP6014592B2 JP6014592B2 (ja) | 2016-10-25 |
Family
ID=42938098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524419A Active JP6014592B2 (ja) | 2010-08-18 | 2011-08-11 | ペプチド放射性トレーサー組成物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9533059B2 (enExample) |
| EP (1) | EP2605802B1 (enExample) |
| JP (1) | JP6014592B2 (enExample) |
| KR (1) | KR101853993B1 (enExample) |
| CN (1) | CN103153350B (enExample) |
| AU (1) | AU2011290856B2 (enExample) |
| BR (1) | BR112013003469A2 (enExample) |
| CA (1) | CA2807491C (enExample) |
| CL (1) | CL2013000483A1 (enExample) |
| ES (1) | ES2626410T3 (enExample) |
| GB (1) | GB201013808D0 (enExample) |
| IL (1) | IL224463A (enExample) |
| MX (1) | MX348733B (enExample) |
| MY (1) | MY163136A (enExample) |
| NZ (1) | NZ606466A (enExample) |
| PH (1) | PH12013500270A1 (enExample) |
| RU (1) | RU2594167C2 (enExample) |
| SG (1) | SG187878A1 (enExample) |
| WO (1) | WO2012022676A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201103696D0 (en) * | 2011-03-04 | 2011-04-20 | Ge Healthcare Ltd | Technetium labelled peptides |
| GB201121914D0 (en) | 2011-12-20 | 2012-02-01 | Ge Healthcare Ltd | Method for patient selection |
| GB201209082D0 (en) * | 2012-05-24 | 2012-07-04 | Ge Healthcare Ltd | Purification method |
| GB201221266D0 (en) * | 2012-11-27 | 2013-01-09 | Ge Healthcare Ltd | Aldehyde compositions |
| GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322451D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Purification method and compositions |
| GB201322456D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| US20190151483A1 (en) * | 2016-07-25 | 2019-05-23 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv | Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof |
| GB201804835D0 (en) * | 2018-03-26 | 2018-05-09 | Ge Healthcare As | Formulation and method of preparation |
| CN114222592A (zh) | 2019-06-14 | 2022-03-22 | 爱丁堡分子成像有限公司 | 化合物和使用方法 |
| GB201915206D0 (en) * | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
| SE2050387A1 (en) * | 2020-04-06 | 2021-10-07 | Pvac Medical Tech Ltd | Labelled substance and methods of detection of inflammation and infection using said substance |
| TW202509086A (zh) * | 2021-03-22 | 2025-03-01 | 日商肽夢想股份有限公司 | c－Met蛋白質結合肽複合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5961955A (en) * | 1997-06-03 | 1999-10-05 | Coulter Pharmaceutical, Inc. | Radioprotectant for peptides labeled with radioisotope |
| WO2003057155A2 (en) | 2001-12-27 | 2003-07-17 | Van Andel Research Institute | Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| ES2396368T3 (es) * | 2003-03-03 | 2013-02-21 | Dyax Corporation | Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos |
| GB0305704D0 (en) * | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
| GB0420344D0 (en) * | 2004-09-14 | 2004-10-13 | Amersham Plc | Diagnostic compounds |
| US20100068150A1 (en) | 2006-07-07 | 2010-03-18 | The Board Of Trustees Of The Leland Stanford Junior University | Selective Caspase Inhibitors |
| GB0615211D0 (en) | 2006-07-31 | 2006-09-06 | Ge Healthcare Uk Ltd | Asymmetric flouro-substituted polymethine dyes |
| US8557776B2 (en) | 2006-09-08 | 2013-10-15 | Bayer Pharma AG | Compounds and methods for 18F labeled agents |
| WO2008072976A2 (en) | 2006-12-13 | 2008-06-19 | Ge Healthcare As | Synthesis of a radiofluorinated peptide using microwave activation technology |
| US8216548B2 (en) * | 2006-12-28 | 2012-07-10 | Ge Healthcare As | Radiofluorination methods |
| EA200901142A1 (ru) * | 2007-03-01 | 2010-04-30 | Байер Шеринг Фарма Акциенгезельшафт | 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники |
| CN101848734B (zh) | 2007-05-16 | 2013-08-28 | 通用电气医疗集团股份有限公司 | 用于成像的经标记的iigf结合肽 |
| GB0718967D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| GB0718957D0 (en) | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
| GB0716897D0 (en) | 2007-08-30 | 2007-10-10 | Univ Muenchen Tech | Cancer imaging and treatment |
| GB0803477D0 (en) | 2008-02-26 | 2008-04-02 | Ge Healthcare As | Therapy selection method |
-
2010
- 2010-08-18 GB GBGB1013808.9A patent/GB201013808D0/en not_active Ceased
-
2011
- 2011-08-11 WO PCT/EP2011/063890 patent/WO2012022676A1/en not_active Ceased
- 2011-08-11 BR BR112013003469A patent/BR112013003469A2/pt active Search and Examination
- 2011-08-11 SG SG2013011770A patent/SG187878A1/en unknown
- 2011-08-11 MX MX2013001939A patent/MX348733B/es active IP Right Grant
- 2011-08-11 US US13/816,589 patent/US9533059B2/en active Active
- 2011-08-11 MY MYPI2013700257A patent/MY163136A/en unknown
- 2011-08-11 JP JP2013524419A patent/JP6014592B2/ja active Active
- 2011-08-11 KR KR1020137006689A patent/KR101853993B1/ko active Active
- 2011-08-11 CN CN201180050137.2A patent/CN103153350B/zh active Active
- 2011-08-11 NZ NZ606466A patent/NZ606466A/en unknown
- 2011-08-11 ES ES11744007.3T patent/ES2626410T3/es active Active
- 2011-08-11 CA CA2807491A patent/CA2807491C/en active Active
- 2011-08-11 EP EP11744007.3A patent/EP2605802B1/en active Active
- 2011-08-11 RU RU2013105491/04A patent/RU2594167C2/ru active
- 2011-08-11 AU AU2011290856A patent/AU2011290856B2/en active Active
- 2011-08-11 PH PH1/2013/500270A patent/PH12013500270A1/en unknown
-
2013
- 2013-01-29 IL IL224463A patent/IL224463A/en active IP Right Grant
- 2013-02-18 CL CL2013000483A patent/CL2013000483A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013540702A5 (enExample) | ||
| JP2013525942A5 (enExample) | ||
| JP2013514381A5 (enExample) | ||
| JP2015503422A5 (enExample) | ||
| JP2012143233A5 (enExample) | ||
| JP2015520667A5 (enExample) | ||
| JP2010219032A5 (enExample) | ||
| JP2016512050A5 (enExample) | ||
| JP2013181136A5 (ja) | ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置 | |
| JP2012531046A5 (enExample) | ||
| JP2012190484A5 (enExample) | ||
| JP2015512729A5 (enExample) | ||
| JP2014102408A5 (enExample) | ||
| JP2014501485A5 (enExample) | ||
| JP2013173781A5 (enExample) | ||
| JP2015528502A5 (enExample) | ||
| JP2015525757A5 (enExample) | ||
| JP2014516397A5 (enExample) | ||
| JP2014517802A5 (enExample) | ||
| JP2015504870A5 (enExample) | ||
| JP2012098988A5 (enExample) | ||
| JP2015501646A5 (enExample) | ||
| IL230635A0 (en) | A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | |
| JP2013500200A5 (enExample) | ||
| JP2013140343A5 (enExample) |